Merck & Co., Inc., Cardiome Pharma Corp. Heart Drug Gets Positive EU Review

LONDON, June 25 (Reuters) - The European Medicines Agency has recommended Merck & Co's (MRK.N) drug Brinavess, or vernakalant, as a treatment for acute atrial fibrillation, or irregular heart beats, the London-based regulator said on Friday.